ArticleJACC. Basic to translational science2017

The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure.

Najah Harouki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.